Logo image of 1ROG.MI

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Price, Quote, News and Overview

BIT:1ROG - Euronext Milan - CH0012032048 - Common Stock - Currency: EUR

274  +274 (+Infinity%)

1ROG.MI Quote, Performance and Key Statistics

ROCHE HOLDING AG-GENUSSCHEIN

BIT:1ROG (7/21/2025, 7:00:00 PM)

274

+274 (+Infinity%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap221.73B
Shares809.25M
Float688.71M
Yearly Dividend10.81
Dividend Yield3.71%
PE13.62
Fwd PE12.3
Earnings (Next)10-23 2025-10-23
IPO05-04 2001-05-04


1ROG.MI short term performance overview.The bars show the price performance of 1ROG.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1ROG.MI long term performance overview.The bars show the price performance of 1ROG.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1ROG.MI is 274 EUR.

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG Daily stock chart

1ROG.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 59.66 663.80B
1LLY.MI ELI LILLY & CO 58.17 647.21B
ZEG.DE ASTRAZENECA PLC 16.81 384.15B
JNJ.DE JOHNSON & JOHNSON 16.85 345.78B
1JNJ.MI JOHNSON & JOHNSON 16.49 338.39B
NOV.DE NOVO NORDISK A/S-B 19.17 268.29B
RHO.DE ROCHE HOLDING AG-BR 14.6 237.76B
SAN.PA SANOFI 11.12 208.12B
1SAN.MI SANOFI 11.08 207.39B
SNW.DE SANOFI 11.06 206.98B
NOT.DE NOVARTIS AG-REG 13.43 193.62B
6MK.DE MERCK & CO. INC. 10.96 182.80B

About 1ROG.MI

Company Profile

1ROG logo image Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Company Info

ROCHE HOLDING AG-GENUSSCHEIN

Grenzacherstrasse 124

Basel BASEL-STADT CH

Employees: 103249

1ROG Company Website

1ROG Investor Relations

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ

What is the stock price of ROCHE HOLDING AG-GENUSSCHEIN today?

The current stock price of 1ROG.MI is 274 EUR.


What is the ticker symbol for ROCHE HOLDING AG-GENUSSCHEIN stock?

The exchange symbol of ROCHE HOLDING AG-GENUSSCHEIN is 1ROG and it is listed on the Euronext Milan exchange.


On which exchange is 1ROG.MI stock listed?

1ROG.MI stock is listed on the Euronext Milan exchange.


What is ROCHE HOLDING AG-GENUSSCHEIN worth?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a market capitalization of 221.73B EUR. This makes 1ROG.MI a Mega Cap stock.


How many employees does ROCHE HOLDING AG-GENUSSCHEIN have?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) currently has 103249 employees.


Is ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) expected to grow?

The Revenue of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is expected to grow by 4.26% in the next year. Check the estimates tab for more information on the 1ROG.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) stock pay dividends?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a dividend yield of 3.71%. The yearly dividend amount is currently 10.81. Check the full fundamental report for a detailed analysis of 1ROG.MI dividend history, reliability and sustainability.


When does ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) report earnings?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) will report earnings on 2025-10-23.


What is the Price/Earnings (PE) ratio of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI)?

The PE ratio for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 13.62. This is based on the reported non-GAAP earnings per share of 20.12 and the current share price of 274 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1ROG.MI.


1ROG.MI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 1ROG.MI.


Chartmill TA Rating
Chartmill Setup Rating

1ROG.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1ROG.MI. 1ROG.MI scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1ROG.MI Financial Highlights

Over the last trailing twelve months 1ROG.MI reported a non-GAAP Earnings per Share(EPS) of 20.12. The EPS increased by 1.24% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.68%
ROA 8.13%
ROE 26.06%
Debt/Equity 0.98
Chartmill High Growth Momentum
EPS Q2Q%1.18%
Sales Q2Q%5.91%
EPS 1Y (TTM)1.24%
Revenue 1Y (TTM)3.03%

1ROG.MI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 71% to 1ROG.MI. The Buy consensus is the average rating of analysts ratings from 27 analysts.

For the next year, analysts expect an EPS growth of 10.74% and a revenue growth 4.26% for 1ROG.MI


Ownership
Inst Owners37.15%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts71.11
Price TargetN/A
EPS Next Y10.74%
Revenue Next Year4.26%